Patents by Inventor Krista McCutcheon

Krista McCutcheon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-LILRB2 ANTIBODIES AND DERIVATIVE PRODUCTS
    Publication number: 20240002503
    Abstract: The present disclosure provides anti-LILRB2 antibodies or antigen-binding fragments thereof, anti-LILRB2 chimeric antigen receptor protein, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.
    Type: Application
    Filed: October 20, 2021
    Publication date: January 4, 2024
    Inventors: Maria Jose COSTA, Ryan STAFFORD, Krista MCCUTCHEON, Jing-Tyan MA, Kyu Hee HONG, Hongyu TIAN, An SONG, X. Charlene LIAO
  • ANTIBODIES AGAINST DENGUE VIRUS AND RELATED METHODS
    Publication number: 20210188948
    Abstract: Provided are antibodies or antigen binding portions thereof that specifically bind Dengue virus, various compositions of such antibodies or antigen binding portions thereof, and methods of their use. The disclosure provides such antibodies, fragments of such antibodies retaining Dengue virus-binding ability, pharmaceutical compositions including such antibodies or antigen binding fragments thereof, and diagnostic compositions including such antibodies or antigen binding fragments thereof. This disclosure further provides for isolated nucleic acids encoding such antibodies, amino acid sequences of such antibodies, and host cells transformed therewith. Additionally, this disclosure provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the disclosure.
    Type: Application
    Filed: August 7, 2019
    Publication date: June 24, 2021
    Inventors: Fabio Zanini, Derek Croote, Makeda L. Robinson, Leslie Goo, Stephen R. Quake, Shirit Einav, Krista McCutcheon, Eric Waltari
  • Compositions and methods for the diagnosis and treatment of tumor
    Patent number: 9815905
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: November 14, 2017
    Assignee: Genentech, Inc.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
    Publication number: 20150023871
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 22, 2015
    Applicant: GENENTECH, INC.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • Compositions and methods for the diagnosis and treatment of tumor
    Patent number: 8877897
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: November 4, 2014
    Assignee: Genentech, Inc.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • Antibodies to lymphotoxin-alpha
    Patent number: 8642740
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: February 4, 2014
    Assignee: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • Antibodies to lymphotoxin-?
    Patent number: 8541552
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: September 24, 2013
    Assignee: Genetech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • ANTIBODIES TO LYMPHOTOXIN-ALPHA
    Publication number: 20130011412
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Application
    Filed: July 6, 2012
    Publication date: January 10, 2013
    Applicant: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • Antibodies to lymphotoxin-?
    Patent number: 8216807
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: July 10, 2012
    Assignee: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • ANTIBODIES TO LYMPHOTOXIN-ALPHA
    Publication number: 20110208673
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Application
    Filed: February 11, 2011
    Publication date: August 25, 2011
    Applicant: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
    Publication number: 20110206702
    Abstract: The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: February 22, 2011
    Publication date: August 25, 2011
    Applicant: Genentech, Inc.
    Inventors: Paul Polakis, Jyoti Asundi, Ron Firestein, Robert F. Kelley, Krista McCutcheon
  • ANTI-PlGF ANTIBODIES AND METHODS USING SAME
    Publication number: 20110171231
    Abstract: The invention provides anti-PlGF antibodies and methods of using the same.
    Type: Application
    Filed: January 12, 2011
    Publication date: July 14, 2011
    Inventors: Carlos Bais, Krista McCutcheon
  • ANTIBODIES TO LYMPHOTOXIN-ALPHA
    Publication number: 20110150865
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Application
    Filed: February 11, 2011
    Publication date: June 23, 2011
    Applicant: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • Antibodies to lymphotoxin-alpha
    Patent number: 7923011
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Grant
    Filed: October 11, 2007
    Date of Patent: April 12, 2011
    Assignee: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT
    Publication number: 20100015055
    Abstract: The present application describes a method for pretreating a biological sample from an autoimmune disease subject in order to avoid interference, especially where the sample is to be subjected to a cell-based biological activity assay, such as a neutralizing antibody assay.
    Type: Application
    Filed: August 31, 2009
    Publication date: January 21, 2010
    Applicant: Genentech, Inc.
    Inventors: Krista McCutcheon, An Song
  • ANTIBODIES TO LYMPHOTOXIN-ALPHA
    Publication number: 20090285830
    Abstract: The invention provides various antibodies that bind to lymphotoxin-?, methods for making such antibodies, compositions and articles incorporating such antibodies, and their uses in treating, for example, an autoimmune disorder. The antibodies include murine, chimeric, and humanized antibodies.
    Type: Application
    Filed: October 11, 2007
    Publication date: November 19, 2009
    Applicant: Genentech, Inc.
    Inventors: Camellia W. Adams, Jane L. Grogan, Austin L. Gurney, Krista McCutcheon
  • Pretreatment of a biological sample from an autoimmune disease subject
    Patent number: 7601335
    Abstract: The present application describes a method for pretreating a biological sample from an autoimmune disease subject in order to avoid interference, especially where the sample is to be subjected to a cell-based biological activity assay, such as a neutralizing antibody assay.
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: October 13, 2009
    Assignee: Genentech, Inc.
    Inventors: Krista McCutcheon, An Song
  • Pretreatment of a biological sample from an autoimmune disease subject
    Publication number: 20060263349
    Abstract: The present application describes a method for pretreating a biological sample from an autoimmune disease subject in order to avoid interference, especially where the sample is to be subjected to a cell-based biological activity assay, such as a neutralizing antibody assay.
    Type: Application
    Filed: May 19, 2006
    Publication date: November 23, 2006
    Inventors: Krista McCutcheon, An Song